Roche receives positive CHMP opinion for Evrysdi, the first and only at home spinal muscular atrophy (SMA) treatment with proven efficacy in adults, children and infants two months and older

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition